The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Exosome Manufacturing Service Market Research Report 2025
Synopsis
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
The global Exosome Manufacturing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Exosome Manufacturing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Manufacturing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Exosome Manufacturing Service in Laboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Exosome Manufacturing Service include Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, SBI, Creative-Biolabs, Esco Aster, EXO Biologics, Eppendorf, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Manufacturing Service.
The Exosome Manufacturing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guidon (Beijing) Pharmaceutical Technology
Cytoniche
EverZom
Lonza
RoosterBio
SBI
Creative-Biolabs
Esco Aster
EXO Biologics
Eppendorf
Aethlon Medical
Segment by Type
Human Embryonic Kidney Cell-Derived Exosomes
Bone Marrow Stem Cell-Derived Exosomes
Immature Dendritic Cell-Derived Exosomes
Milk-Derived Exosomes
Red Blood Cell-Derived Exosomes
Others
Segment by Application
Laboratory
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
The global Exosome Manufacturing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Exosome Manufacturing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Manufacturing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Exosome Manufacturing Service in Laboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Exosome Manufacturing Service include Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, SBI, Creative-Biolabs, Esco Aster, EXO Biologics, Eppendorf, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Manufacturing Service.
The Exosome Manufacturing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guidon (Beijing) Pharmaceutical Technology
Cytoniche
EverZom
Lonza
RoosterBio
SBI
Creative-Biolabs
Esco Aster
EXO Biologics
Eppendorf
Aethlon Medical
Segment by Type
Human Embryonic Kidney Cell-Derived Exosomes
Bone Marrow Stem Cell-Derived Exosomes
Immature Dendritic Cell-Derived Exosomes
Milk-Derived Exosomes
Red Blood Cell-Derived Exosomes
Others
Segment by Application
Laboratory
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Manufacturing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Human Embryonic Kidney Cell-Derived Exosomes
1.2.3 Bone Marrow Stem Cell-Derived Exosomes
1.2.4 Immature Dendritic Cell-Derived Exosomes
1.2.5 Milk-Derived Exosomes
1.2.6 Red Blood Cell-Derived Exosomes
1.2.7 Others
1.3 Market by Application
1.3.1 Global Exosome Manufacturing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Manufacturing Service Market Perspective (2019-2030)
2.2 Global Exosome Manufacturing Service Growth Trends by Region
2.2.1 Global Exosome Manufacturing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Manufacturing Service Historic Market Size by Region (2019-2024)
2.2.3 Exosome Manufacturing Service Forecasted Market Size by Region (2025-2030)
2.3 Exosome Manufacturing Service Market Dynamics
2.3.1 Exosome Manufacturing Service Industry Trends
2.3.2 Exosome Manufacturing Service Market Drivers
2.3.3 Exosome Manufacturing Service Market Challenges
2.3.4 Exosome Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Manufacturing Service Players by Revenue
3.1.1 Global Top Exosome Manufacturing Service Players by Revenue (2019-2024)
3.1.2 Global Exosome Manufacturing Service Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Exosome Manufacturing Service Revenue
3.4 Global Exosome Manufacturing Service Market Concentration Ratio
3.4.1 Global Exosome Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Manufacturing Service Revenue in 2023
3.5 Global Key Players of Exosome Manufacturing Service Head office and Area Served
3.6 Global Key Players of Exosome Manufacturing Service, Product and Application
3.7 Global Key Players of Exosome Manufacturing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Manufacturing Service Breakdown Data by Type
4.1 Global Exosome Manufacturing Service Historic Market Size by Type (2019-2024)
4.2 Global Exosome Manufacturing Service Forecasted Market Size by Type (2025-2030)
5 Exosome Manufacturing Service Breakdown Data by Application
5.1 Global Exosome Manufacturing Service Historic Market Size by Application (2019-2024)
5.2 Global Exosome Manufacturing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Manufacturing Service Market Size (2019-2030)
6.2 North America Exosome Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosome Manufacturing Service Market Size by Country (2019-2024)
6.4 North America Exosome Manufacturing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Manufacturing Service Market Size (2019-2030)
7.2 Europe Exosome Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosome Manufacturing Service Market Size by Country (2019-2024)
7.4 Europe Exosome Manufacturing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Manufacturing Service Market Size (2019-2030)
8.2 Asia-Pacific Exosome Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosome Manufacturing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosome Manufacturing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Manufacturing Service Market Size (2019-2030)
9.2 Latin America Exosome Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosome Manufacturing Service Market Size by Country (2019-2024)
9.4 Latin America Exosome Manufacturing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Manufacturing Service Market Size (2019-2030)
10.2 Middle East & Africa Exosome Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosome Manufacturing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosome Manufacturing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Guidon (Beijing) Pharmaceutical Technology
11.1.1 Guidon (Beijing) Pharmaceutical Technology Company Details
11.1.2 Guidon (Beijing) Pharmaceutical Technology Business Overview
11.1.3 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Introduction
11.1.4 Guidon (Beijing) Pharmaceutical Technology Revenue in Exosome Manufacturing Service Business (2019-2024)
11.1.5 Guidon (Beijing) Pharmaceutical Technology Recent Development
11.2 Cytoniche
11.2.1 Cytoniche Company Details
11.2.2 Cytoniche Business Overview
11.2.3 Cytoniche Exosome Manufacturing Service Introduction
11.2.4 Cytoniche Revenue in Exosome Manufacturing Service Business (2019-2024)
11.2.5 Cytoniche Recent Development
11.3 EverZom
11.3.1 EverZom Company Details
11.3.2 EverZom Business Overview
11.3.3 EverZom Exosome Manufacturing Service Introduction
11.3.4 EverZom Revenue in Exosome Manufacturing Service Business (2019-2024)
11.3.5 EverZom Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Exosome Manufacturing Service Introduction
11.4.4 Lonza Revenue in Exosome Manufacturing Service Business (2019-2024)
11.4.5 Lonza Recent Development
11.5 RoosterBio
11.5.1 RoosterBio Company Details
11.5.2 RoosterBio Business Overview
11.5.3 RoosterBio Exosome Manufacturing Service Introduction
11.5.4 RoosterBio Revenue in Exosome Manufacturing Service Business (2019-2024)
11.5.5 RoosterBio Recent Development
11.6 SBI
11.6.1 SBI Company Details
11.6.2 SBI Business Overview
11.6.3 SBI Exosome Manufacturing Service Introduction
11.6.4 SBI Revenue in Exosome Manufacturing Service Business (2019-2024)
11.6.5 SBI Recent Development
11.7 Creative-Biolabs
11.7.1 Creative-Biolabs Company Details
11.7.2 Creative-Biolabs Business Overview
11.7.3 Creative-Biolabs Exosome Manufacturing Service Introduction
11.7.4 Creative-Biolabs Revenue in Exosome Manufacturing Service Business (2019-2024)
11.7.5 Creative-Biolabs Recent Development
11.8 Esco Aster
11.8.1 Esco Aster Company Details
11.8.2 Esco Aster Business Overview
11.8.3 Esco Aster Exosome Manufacturing Service Introduction
11.8.4 Esco Aster Revenue in Exosome Manufacturing Service Business (2019-2024)
11.8.5 Esco Aster Recent Development
11.9 EXO Biologics
11.9.1 EXO Biologics Company Details
11.9.2 EXO Biologics Business Overview
11.9.3 EXO Biologics Exosome Manufacturing Service Introduction
11.9.4 EXO Biologics Revenue in Exosome Manufacturing Service Business (2019-2024)
11.9.5 EXO Biologics Recent Development
11.10 Eppendorf
11.10.1 Eppendorf Company Details
11.10.2 Eppendorf Business Overview
11.10.3 Eppendorf Exosome Manufacturing Service Introduction
11.10.4 Eppendorf Revenue in Exosome Manufacturing Service Business (2019-2024)
11.10.5 Eppendorf Recent Development
11.11 Aethlon Medical
11.11.1 Aethlon Medical Company Details
11.11.2 Aethlon Medical Business Overview
11.11.3 Aethlon Medical Exosome Manufacturing Service Introduction
11.11.4 Aethlon Medical Revenue in Exosome Manufacturing Service Business (2019-2024)
11.11.5 Aethlon Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Exosome Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Human Embryonic Kidney Cell-Derived Exosomes
Table 3. Key Players of Bone Marrow Stem Cell-Derived Exosomes
Table 4. Key Players of Immature Dendritic Cell-Derived Exosomes
Table 5. Key Players of Milk-Derived Exosomes
Table 6. Key Players of Red Blood Cell-Derived Exosomes
Table 7. Key Players of Others
Table 8. Global Exosome Manufacturing Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Exosome Manufacturing Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Exosome Manufacturing Service Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Exosome Manufacturing Service Market Share by Region (2019-2024)
Table 12. Global Exosome Manufacturing Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Exosome Manufacturing Service Market Share by Region (2025-2030)
Table 14. Exosome Manufacturing Service Market Trends
Table 15. Exosome Manufacturing Service Market Drivers
Table 16. Exosome Manufacturing Service Market Challenges
Table 17. Exosome Manufacturing Service Market Restraints
Table 18. Global Exosome Manufacturing Service Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Exosome Manufacturing Service Market Share by Players (2019-2024)
Table 20. Global Top Exosome Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Manufacturing Service as of 2023)
Table 21. Ranking of Global Top Exosome Manufacturing Service Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Exosome Manufacturing Service Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of Exosome Manufacturing Service, Headquarters and Area Served
Table 24. Global Key Players of Exosome Manufacturing Service, Product and Application
Table 25. Global Key Players of Exosome Manufacturing Service, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Exosome Manufacturing Service Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Exosome Manufacturing Service Revenue Market Share by Type (2019-2024)
Table 29. Global Exosome Manufacturing Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Exosome Manufacturing Service Revenue Market Share by Type (2025-2030)
Table 31. Global Exosome Manufacturing Service Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Exosome Manufacturing Service Revenue Market Share by Application (2019-2024)
Table 33. Global Exosome Manufacturing Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Exosome Manufacturing Service Revenue Market Share by Application (2025-2030)
Table 35. North America Exosome Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Exosome Manufacturing Service Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Exosome Manufacturing Service Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Exosome Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Exosome Manufacturing Service Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Exosome Manufacturing Service Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Exosome Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Exosome Manufacturing Service Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Exosome Manufacturing Service Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Exosome Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Exosome Manufacturing Service Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Exosome Manufacturing Service Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Exosome Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Exosome Manufacturing Service Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Exosome Manufacturing Service Market Size by Country (2025-2030) & (US$ Million)
Table 50. Guidon (Beijing) Pharmaceutical Technology Company Details
Table 51. Guidon (Beijing) Pharmaceutical Technology Business Overview
Table 52. Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product
Table 53. Guidon (Beijing) Pharmaceutical Technology Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 54. Guidon (Beijing) Pharmaceutical Technology Recent Development
Table 55. Cytoniche Company Details
Table 56. Cytoniche Business Overview
Table 57. Cytoniche Exosome Manufacturing Service Product
Table 58. Cytoniche Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 59. Cytoniche Recent Development
Table 60. EverZom Company Details
Table 61. EverZom Business Overview
Table 62. EverZom Exosome Manufacturing Service Product
Table 63. EverZom Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 64. EverZom Recent Development
Table 65. Lonza Company Details
Table 66. Lonza Business Overview
Table 67. Lonza Exosome Manufacturing Service Product
Table 68. Lonza Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 69. Lonza Recent Development
Table 70. RoosterBio Company Details
Table 71. RoosterBio Business Overview
Table 72. RoosterBio Exosome Manufacturing Service Product
Table 73. RoosterBio Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 74. RoosterBio Recent Development
Table 75. SBI Company Details
Table 76. SBI Business Overview
Table 77. SBI Exosome Manufacturing Service Product
Table 78. SBI Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 79. SBI Recent Development
Table 80. Creative-Biolabs Company Details
Table 81. Creative-Biolabs Business Overview
Table 82. Creative-Biolabs Exosome Manufacturing Service Product
Table 83. Creative-Biolabs Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 84. Creative-Biolabs Recent Development
Table 85. Esco Aster Company Details
Table 86. Esco Aster Business Overview
Table 87. Esco Aster Exosome Manufacturing Service Product
Table 88. Esco Aster Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 89. Esco Aster Recent Development
Table 90. EXO Biologics Company Details
Table 91. EXO Biologics Business Overview
Table 92. EXO Biologics Exosome Manufacturing Service Product
Table 93. EXO Biologics Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 94. EXO Biologics Recent Development
Table 95. Eppendorf Company Details
Table 96. Eppendorf Business Overview
Table 97. Eppendorf Exosome Manufacturing Service Product
Table 98. Eppendorf Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 99. Eppendorf Recent Development
Table 100. Aethlon Medical Company Details
Table 101. Aethlon Medical Business Overview
Table 102. Aethlon Medical Exosome Manufacturing Service Product
Table 103. Aethlon Medical Revenue in Exosome Manufacturing Service Business (2019-2024) & (US$ Million)
Table 104. Aethlon Medical Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Authors List of This Report
List of Figures
Figure 1. Exosome Manufacturing Service Picture
Figure 2. Global Exosome Manufacturing Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Exosome Manufacturing Service Market Share by Type: 2023 VS 2030
Figure 4. Human Embryonic Kidney Cell-Derived Exosomes Features
Figure 5. Bone Marrow Stem Cell-Derived Exosomes Features
Figure 6. Immature Dendritic Cell-Derived Exosomes Features
Figure 7. Milk-Derived Exosomes Features
Figure 8. Red Blood Cell-Derived Exosomes Features
Figure 9. Others Features
Figure 10. Global Exosome Manufacturing Service Market Size by Application (2024-2030) & (US$ Million)
Figure 11. Global Exosome Manufacturing Service Market Share by Application: 2023 VS 2030
Figure 12. Laboratory Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Others Case Studies
Figure 15. Exosome Manufacturing Service Report Years Considered
Figure 16. Global Exosome Manufacturing Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Exosome Manufacturing Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Exosome Manufacturing Service Market Share by Region: 2023 VS 2030
Figure 19. Global Exosome Manufacturing Service Market Share by Players in 2023
Figure 20. Global Top Exosome Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Manufacturing Service as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Exosome Manufacturing Service Revenue in 2023
Figure 22. North America Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Exosome Manufacturing Service Market Share by Country (2019-2030)
Figure 24. United States Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Exosome Manufacturing Service Market Share by Country (2019-2030)
Figure 28. Germany Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Exosome Manufacturing Service Market Share by Region (2019-2030)
Figure 36. China Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Exosome Manufacturing Service Market Share by Country (2019-2030)
Figure 44. Mexico Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Exosome Manufacturing Service Market Share by Country (2019-2030)
Figure 48. Turkey Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. UAE Exosome Manufacturing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Guidon (Beijing) Pharmaceutical Technology Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 52. Cytoniche Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 53. EverZom Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 54. Lonza Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 55. RoosterBio Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 56. SBI Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 57. Creative-Biolabs Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 58. Esco Aster Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 59. EXO Biologics Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 60. Eppendorf Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 61. Aethlon Medical Revenue Growth Rate in Exosome Manufacturing Service Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
